Literature DB >> 22960659

Conditional disruption of Axin1 leads to development of liver tumors in mice.

Gui Jie Feng1, Welwyn Cotta, Xiao Qing Wei, Oliver Poetz, Rebecca Evans, Thierry Jardé, Karen Reed, Valerie Meniel, Geraint T Williams, Alan R Clarke, Trevor C Dale.   

Abstract

BACKGROUND & AIMS: Mutations in components of the Wnt signaling pathway, including β-catenin and AXIN1, are found in more than 50% of human hepatocellular carcinomas (HCCs). Disruption of Axin1 causes embryonic lethality in mice. We generated mice with conditional disruption of Axin1 to study its function specifically in adult liver.
METHODS: Mice with a LoxP-flanked allele of Axin1 were generated by homologous recombination. Mice homozygous for the Axin1fl/fl allele were crossed with AhCre mice; in offspring, Axin1 was disrupted in liver following injection of β-naphthoflavone (Axin1fl/fl/Cre mice). Liver tissues were collected and analyzed by quantitative real-time polymerase chain reaction and immunoprecipitation, histology, and immunoblot assays.
RESULTS: Deletion of Axin1 from livers of adult mice resulted in an acute and persistent increase in hepatocyte cell volume, proliferation, and transcription of genes that induce the G(2)/M transition in the cell cycle and cytokinesis. A subset of Wnt target genes was activated, including Axin2, c-Myc, and cyclin D1. However, loss of Axin1 did not increase nuclear levels of β-catenin or cause changes in liver zonation that have been associated with loss of the adenomatous polyposis coli (APC) or constitutive activation of β-catenin. After 1 year, 5 of 9 Axin1fl/fl/Cre mice developed liver tumors with histologic features of HCC.
CONCLUSIONS: Hepatocytes from adult mice with conditional disruption of Axin1 in liver have a transcriptional profile that differs from that associated with loss of APC or constitutive activation of β-catenin. It might be similar to a proliferation profile observed in a subset of human HCCs with mutations in AXIN1. Axin1fl/fl mice could be a useful model of AXIN1-associated tumorigenesis and HCC.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960659     DOI: 10.1053/j.gastro.2012.08.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

2.  Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

Authors:  Wantae Kim; Sanjoy Kumar Khan; Jelena Gvozdenovic-Jeremic; Youngeun Kim; Jason Dahlman; Hanjun Kim; Ogyi Park; Tohru Ishitani; Eek-Hoon Jho; Bin Gao; Yingzi Yang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

3.  Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.

Authors:  Yu Qiao; Jingxiao Wang; Eylul Karagoz; Binyong Liang; Xinhua Song; Runze Shang; Katja Evert; Meng Xu; Li Che; Matthias Evert; Diego F Calvisi; Junyan Tao; Bruce Wang; Satdarshan P Monga; Xin Chen
Journal:  Hepatology       Date:  2019-04-11       Impact factor: 17.425

4.  Vitamin D receptor is a novel transcriptional regulator for Axin1.

Authors:  Dapeng Jin; Yong-Guo Zhang; Shaoping Wu; Rong Lu; Zhijie Lin; Yuanyuan Zheng; Honglei Chen; Gabriella Cs-Szabo; Jun Sun
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-04       Impact factor: 4.292

Review 5.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

6.  WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes.

Authors:  Patricia Rada; Ana I Rojo; Anika Offergeld; Gui Jie Feng; Juan P Velasco-Martín; José Manuel González-Sancho; Ángela M Valverde; Trevor Dale; Javier Regadera; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-12-09       Impact factor: 8.401

Review 7.  AXIN1 and AXIN2 variants in gastrointestinal cancers.

Authors:  Serina M Mazzoni; Eric R Fearon
Journal:  Cancer Lett       Date:  2014-09-16       Impact factor: 8.679

Review 8.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 9.  Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Authors:  Dustin J Flanagan; Elizabeth Vincan; Toby J Phesse
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

Review 10.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.